Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Immune Response to COVID19 Vaccination in Immunodeficient Patients

NCT05286242 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT05286242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05286242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Immune Response to COVID19 Vaccination in Immunodeficient Patients
Lead sponsor
Yale University
Phase
Observational
Overall status
Completed
Start date
February 10, 2021
Completion date
May 22, 2026
Enrollment
196 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune blistering disease, b-cell deficiency, multiple sclerosis